RLMD (STOCKS)
Relmada Therapeutics, Inc. Common Stock
$3.210000
-0.030000 (-0.93%)
Prev close: $3.240000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Sergio Traversa
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $341.88M
- Employees
- 17
- P/E (TTM)
- -3.48
- P/B (TTM)
- 1.67
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
6
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.11 | $-0.20 | +0.0935 | +45.95% |
|
Mar 2026 (Q1)
|
$-0.22 | $-0.20 | -0.0211 | -10.61% |
|
Dec 2025 (Q4)
|
$-0.29 | $-0.14 | -0.1472 | -103.08% |
|
Sep 2025 (Q3)
|
$-0.30 | $-0.12 | -0.1817 | -153.59% |